10x Genomics, Inc. — Director's Dealing 2023

Mar 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2023-03-21

Reporting Person: Hindson Benjamin J. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-21	Class A Common Stock	A	36387	—	Acquired	286624	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-21	Stock Option (right to buy)	$50.1	A	36387	Acquired	2033-03-21	Class A Common Stock (36387)	Direct
2023-03-21	Performance- based Restricted Stock Units	$	A	18194	Acquired	2028-04-01	Class A Common Stock (18194)	Direct

Footnotes

F1: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest
on each quarterly anniversary measured from February 21, 2023, subject to the Reporting Person continuing as a service provider through each such date.

F2: 1/48th of the total number of shares subject to the option vest on each monthly anniversary measured from April 1, 2023, subject to the Reporting Person continuing as a
service provider through each such date.

F3: Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest
upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through
each such date.